Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on: January 07,2024

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on:January 07,2024

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on: December 30,2023

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on:December 30,2023

Gene loss enhances metastasis and cancer progression

by Melissa Rohman,Northwestern UniversityAn in vivo genome-wide CRISPR-Cas9 KO screen identifying CTC-promoting genetic factors. (A) Experimental design of the genome-wide CRISPR-Cas9 KO screen

Updated on: December 25,2023

Gene loss enhances metastasis and cancer progression

by Melissa Rohman,Northwestern UniversityAn in vivo genome-wide CRISPR-Cas9 KO screen identifying CTC-promoting genetic factors. (A) Experimental design of the genome-wide CRISPR-Cas9 KO screen

Updated on:December 25,2023

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on: January 11,2024

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on:January 11,2024

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on: January 26,2024

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on:January 26,2024

Study shows which patients with advanced prostate cancer will benefit from chemotherapy

by University College LondonProstate cancer cells. Credit: NIH Image GalleryResearchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chem

Updated on: April 03,2024

Study shows which patients with advanced prostate cancer will benefit from chemotherapy

by University College LondonProstate cancer cells. Credit: NIH Image GalleryResearchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chem

Updated on:April 03,2024

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on: December 25,2023

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on:December 25,2023

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on: December 28,2023

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on:December 28,2023

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or

Updated on: December 20,2023

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or

Updated on:December 20,2023

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including

Updated on: December 28,2023

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including

Updated on:December 28,2023

Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related

Updated on: December 18,2023

Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related

Updated on:December 18,2023

Patients with HPV-positive oropharynx cancer should receive chemoradiation

byEuropean Society for Medical OncologyProf Hisham Mehanna, Chair, Head and Neck Surgery, Institute of Cancer and Genomic Sciences, University of Birmingham, UK, study author. Credit: © European

Updated on: December 18,2023

Patients with HPV-positive oropharynx cancer should receive chemoradiation

byEuropean Society for Medical OncologyProf Hisham Mehanna, Chair, Head and Neck Surgery, Institute of Cancer and Genomic Sciences, University of Birmingham, UK, study author. Credit: © European

Updated on:December 18,2023